Robert A. Nichols to Neuroprotective Agents
This is a "connection" page, showing publications Robert A. Nichols has written about Neuroprotective Agents.
Connection Strength
1.267
-
Forest KH, Nichols RA. Assessing Neuroprotective Agents for A?-Induced Neurotoxicity. Trends Mol Med. 2019 08; 25(8):685-695.
Score: 0.560
-
Forest KH, Alfulaij N, Arora K, Taketa R, Sherrin T, Todorovic C, Lawrence JLM, Yoshikawa GT, Ng HL, Hruby VJ, Nichols RA. Protection against ?-amyloid neurotoxicity by a non-toxic endogenous N-terminal ?-amyloid fragment and its active hexapeptide core sequence. J Neurochem. 2018 01; 144(2):201-217.
Score: 0.504
-
Tan X, Liang Z, Li Y, Zhi Y, Yi L, Bai S, Forest KH, Nichols RA, Dong Y, Li QX. Isoorientin, a GSK-3? inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice. Behav Brain Res. 2021 02 01; 398:112968.
Score: 0.153
-
Roberts CF, Cao Y, Im W, Nichols RA, Lukas RJ, George AA. Neuroprotective amyloid ? N-terminal peptides differentially alter human a7- and a7?2-nicotinic acetylcholine (nACh) receptor single-channel properties. Br J Pharmacol. 2024 Sep; 181(17):3172-3191.
Score: 0.049